F 0554
Allow residents to self-administer drugs if determined clinically appropriate.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview and record review, the facility failed to monitor medication administration of an
inhalation medication for one Resident #50 of 3 Residents on inhalation medication.
Residents Affected - Few
Findings Included:
During observation of Resident #50 on 10/8/20 at 8:15 a.m. the resident was sitting up in his wheelchair
with a nebulizer mask covering his face. The resident was observed moving the mask with his hands. The
door to his room was open and the curtain was closed between the two beds. The resident was looking out
into the hallway and mumbling.
Staff member B, RN was observed going into another resident room across the hall with the door shut from
8:22 a.m. to 8:25 a.m. Staff member B, RN peeked into Resident #50's room and partially shut the door to
the room and stayed in the hallway talking to a resident until 8:37 a.m. when she removed the mask and
rinsed with water, dried and placed in the bag. Staff member B, RN stated she does not listen to Residents'
lungs before or after inhalation treatment and stated Resident #50 has to be watched with the nebulizer as
he will rip the mask off.
An interview with Staff member B, RN on 10/8/20 at 8:40 a.m. revealed Resident #50 gets nebulizer
treatments every 4 hours. Staff member B, RN said the resident will tell you when he is done on occasion
and sometimes will just take the mask off.
Review of the physician orders revealed the resident receives ipratroprium-albuterol solution for
nebulization every 4 hours dated 5/27/20.
Review of the self-administration of medication informed consent and assessment dated [DATE] revealed
Resident #50's box checked as I wish to have the med nurse administer my medications.
Review of the Resident #50's minimum data set (MDS) section C revealed a Brief interview for mental
status (BIMS) of 6 indicated severe cognitive impairment.
Review of the care plan revealed the resident's family elected to pursue palliative care due to severe
cognitive declines, initiated on 8/20/20, edited on 9/8/20. The approach documented was to administer
medications for shortness of breath as needed and ordered by physician. Monitor for side effects and
effectiveness created 8/21/20. Provide total nursing care as needed dated 8/20/20.
Review of the policy for Self-administration of medication effective date 7/10/19, page one of three,
revealed: A resident may self-administer medications if the interdisciplinary team has determined
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 7
Event ID:
106006
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
106006
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/09/2020
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baldomero Lopez Memorial Veterans Nursing Home
6919 Parkway Blvd
Land O Lakes, FL 34639
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0554
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
that the practice is safe. The resident will be assessed fro their cognitive, physical and visual ability to
self-administer medications based on the attached form Self Administration of Medication Informed
Consent and Assessment. If the interdisciplinary care team determines that the resident cannot safely
self-administer medications, medications will be administered by the staff nurse.
Review of the procedure guidelines for Administering nebulizer therapy (not dated, page 240 from unknown
document) one page revealed: Nursing action 1. Auscultate breath sounds, monitor the heart rate before
and after the treatment for patients using bronchodilators drugs. 4. Instruct the patient to exhale. 7.
Observed expansion of chest to ascertain that patient is taking deep breaths. 8. Instruct the patient to
breathe slowly and deeply until all the medication is nebulized. 9. On completion of the treatment,
encourage the patient to cough after several deep breaths.
Event ID:
Facility ID:
106006
If continuation sheet
Page 2 of 7
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
106006
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/09/2020
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baldomero Lopez Memorial Veterans Nursing Home
6919 Parkway Blvd
Land O Lakes, FL 34639
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0757
Ensure each resident’s drug regimen must be free from unnecessary drugs.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
record review and interview, the facility did not ensure that 1 (Resident #76) out of 5 residents reviewed for
unnecessary medications had a diagnosis or indication for use listed for all medications on the active order
list.
Residents Affected - Few
Findings included:
Resident #76 was admitted to the facility on [DATE] with diagnoses that included, but were not limited to
acute respiratory failure, pneumonia, and primary insomnia.
Review of the resident's active orders revealed that the resident had an order for melatonin OTC (over the
counter) 1 tablet 3mg PO (by mouth) QHS (every night at bedtime) dated 10/02/19. There was no diagnosis
or indication for use listed for the medication.
The resident also had an order for Siltussin DM DAS (dextromethorphan-guaifenesin) OTC liquid
10-100mg/5ml 10ml orally every 4 hours dated 12/09/19. There was no diagnosis or indication for use listed
for the medication.
On 10/09/20 at 1:16 PM in an interview with the Director of Nursing (DON), she said that there should be a
diagnosis for each medication.
When asked what melatonin was used for, she said it was used as a sleep aide. When asked what Siltussin
DM was used for, she said it was for a cough.
The DON acknowledged that there was no diagnosis or indication for use on either medication. She said
that she didn't know why there wasn't a diagnosis or indication listed for either of the medications, but that
there should be one.
On 10/09/20 at 1:27 PM in an interview with Staff F, pharmacist, she said that she was not the normal
pharmacist, so she could not speak to a specific resident, but that she could give her expectations as a
pharmacist. She said that she would expect every medication to have at least one diagnosis related to use
listed on the order, like insomnia for the melatonin or an indication of use, like cough for the Siltussin DM.
On 10/09/20 at 1:29 PM, during a phone interview with Staff G, the facility's full-time pharmacist she said
that all medications should have a diagnosis. She asked if the order list we had received from the facility
had diagnoses printed with it. Staff F, who was present for the telephone interview, told Staff G that yes, the
version we had did include diagnoses. Staff F also relayed to Staff G that there were no diagnoses or
indication for use for either of the medications in question. Staff G said that it is her expectation that all
medications have a diagnosis.
Review of a facility policy Verbal and/or Telephone Physicians' Orders effective on 5/30/2009 revealed
under the heading II. PROCEDURES . 4. The verbal or telephone order shall be documented by the
professional who accepts the order and shall include: . e. Purpose or indication for a medication
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
106006
If continuation sheet
Page 3 of 7
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
106006
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/09/2020
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baldomero Lopez Memorial Veterans Nursing Home
6919 Parkway Blvd
Land O Lakes, FL 34639
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0758
Level of Harm - Minimal harm
or potential for actual harm
Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated,
prior to initiating or instead of continuing psychotropic medication; and PRN orders for psychotropic
medications are only used when the medication is necessary and PRN use is limited.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 2.
Residents Affected - Few
On 10/09/20 at 10:50 a.m., Resident #3 was observed sitting in the wheelchair next to the bed in his room.
He was well groomed and dressed for the day.
A review of the Resident Face Sheet for Resident #3 revealed that he was initially admitted into the facility
on [DATE] with a primary diagnosis of Alzheimer's Disease. Other diagnoses included but were not limited
to post-traumatic stress disorder, major depressive disorder, and generalized anxiety disorder.
A review of Section C of the Quarterly Minimum Data Set (MDS) dated [DATE] revealed that the resident
was rarely/never understood. Section D indicated that the resident was rarely/never understood. The
section related to feeling down, depressed, or hopeless was blank. Section N revealed that Resident #3
received an antidepressant for 7 days per week.
A review of the Physician Order Reports for 08/01/20-08/31/20, 09/01/20-09/30/20, and 10/01/20-10/09/20
revealed that Resident #3 had the following orders:
Memantine- 10 mg twice per day for dementia
Sertraline- 50 mg once per day for depression
There was no order for Behavior Monitoring found on the Physician Order Reports.
A review of the Medications Administration History for 08/01/20-08/31/20, 09/01/20-09/30/20, and
10/01/20-10/09/20 did not reflect that Resident #3's behaviors were monitored.
A review of the Treatment Administration History for 08/01/20-08/31/20, 09/01/20-09/30/20, and
10/01/20-10/09/20 did not reflect that Resident #3's behaviors were monitored.
A review of the Resident Progress Notes for August, September, and October did not reflect daily
documentation for non-verbal signs of anxiety, mood and behavior monitoring.
The care plan for behavioral symptoms had a start date of 01/16/19. Interventions included but were not
limited to monitor behavior episodes and attempt to determine underlying causes, document behavior and
potential causes, and monitor for and document presence of mood and behaviors. The care plan for
psychotropic drug use had a start date of 01/16/19. Interventions included but were not limited to monitor
for non-verbal signs of anxiety and monitor Resident #3 frequently for mood and behaviors.
On 10/09/20 at 10:24 a.m., the MDS Coordinator stated that behavior monitoring should be documented in
progress notes.
On 10/09/20 at 10:48 a.m., Staff A, Nursing Supervisor, reported that Resident #3 did not have any
behaviors, but can be resistive to care often. Staff A reported that he was not combative or
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
106006
If continuation sheet
Page 4 of 7
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
106006
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/09/2020
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baldomero Lopez Memorial Veterans Nursing Home
6919 Parkway Blvd
Land O Lakes, FL 34639
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0758
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
anything. She reported that behaviors would be monitored if a resident was taking psychotropic
medications. If a resident was monitored for behaviors, it would pop up on the Medication Administration
Record (MAR) and it should be documented every shift. If they are not on a psychotropic, then behaviors
would be documented in the progress notes. Staff A reported that she was not sure what medications
Resident #3 was ordered. At 10:54 a.m., she looked up the resident's orders. She stated that he had an
order for sertraline, but not an antipsychotic. Staff A stated that Resident #3 does not like to particularly be
changed, but he was not combative.
The policy Psychotropic Medication Clinical Guidelines revised on 10/06/17 revealed the following:
Standard
Psychotropic Drug is any drug that affects brain activities associated with mental processes and behavior.
These drugs include, but are not limited to drugs in the following categories:
Antipsychotics
Antianxiety
Antidepressants
Hypnotics
Nursing
1. Daily monitoring of the resident for presence of target behaviors and any adverse effects of the
medication (charting behaviors/adverse effects when present)
2. Review the use of the psychotropic medication with the interdisciplinary team on a quarterly basis to
include presence of target behaviors and/or adverse effects of the medication.
Pharmacist
1. Monitors psychotropic drug use in the facility to ensure appropriate use/monitoring of medications.
Based on interview and record review, the facility did not ensure 1. that 2 (Resident's #76 and #3) out of 5
residents reviewed for unnecessary medications were being monitored for behaviors related to the use of
psychotropic medications; and 2. that a care plan related to monitoring the effectiveness of psychotropic
medications was implemented for 2 (Resident #76 and #3) out of 5 residents reviewed for unnecessary
medications.
Findings included:
1.
On 10/09/20 at 1:16 PM in an interview with the Director of Nursing (DON), she said that behaviors for
psychotropic medications are documented on the eMAR (electronic medication administration record). She
said that behaviors should be monitored for psychotropic medication every shift.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
106006
If continuation sheet
Page 5 of 7
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
106006
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/09/2020
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baldomero Lopez Memorial Veterans Nursing Home
6919 Parkway Blvd
Land O Lakes, FL 34639
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0758
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
When she was asked if anti-depressants were considered psychotropic medication, she said I don't think
so. When asked if nurses should be monitoring behaviors for residents who are taking anti-depressants,
she said we only monitor anti-psychotics every shift. With residents who are taking anti-depressants, we go
by the PHQ-9 tool (section D of the Minimum Data Set (MDS) assessment) done by our Social Services
(SS) Department quarterly. SS monitors all residents quarterly with the PHQ-9 tool, and nurses document
in the notes if the resident has any behaviors. She was asked to clarify what the PHQ-9 was and told us
that the PHQ-9 is a tool to determine if there is any indication of depression for all residents.
On 10/09/20 at 1:27 PM Staff F, pharmacist said that she was not the facility's full-time regular pharmacist,
but that she was in the facility covering the regular pharmacist's vacation. She said that she could give her
expectations as a pharmacist, but not about a resident specific. She said that she would expect to see
behaviors monitored, even if there were no behaviors that should be documented. She believes that the
monitoring should be done when the nurse gives the medication, not every shift.
On10/09/20 at 1:29 PM, during the interview with Staff F, the facility's regular pharmacist Staff G, by
request of the DON, called to answer surveyor questions. Staff G said that behaviors should be monitored
every shift, and that there are questions on each eMAR about behaviors. She said the nursing staff should
be monitoring residents if they are having behaviors and documenting how many times the residents are
having those behaviors. If a resident has no behaviors, that should be documented as well. Behavior
monitoring is part of a standard nursing order set that should go along with all psychotropic medication
ordered. If the resident gets an order for a psychotropic, they should be adding the order set that includes
behavior monitoring and side-effect monitoring. When asked if nurses should be monitoring residents on
anti-depressants every shift for behaviors, Staff G said that if they are on the anti-depressant, we are only
monitoring side effects. Those behaviors don't change shift to shift, so we use the PHQOV or PHQ-9 (filled
out) by social services every quarter.
Resident #76 was initially admitted to the facility on [DATE] for a diagnosis of acute respiratory failure with
hypoxia. Other diagnoses included, but not limited to, eczema of face, cognitive communication deficit,
unspecified convulsions, primary insomnia and chronic pain syndrome.
Review of the Resident #76's most recent quarterly MDS dated [DATE] the resident was assessed to have
a BIMS (brief interview for mental status) of 14, indicating the resident had intact cognitive responses. The
resident was assessed to feel tired or have little energy 7-11 days during a 14-day assessment period, and
to refuse or reject care 4-6 days of a 7-day assessment period. The resident was assessed to receive an
antidepressant daily.
The resident had orders that included, but were not limited to:
Carbamazepine 200mg tablet oral every 12 hours for seizure disorder dated 5/23/2019
Citalopram 20mg one tablet orally at bedtime for depression dated 5/17/2019
Trazodone 100mg one tab orally at bedtime for depression dated 5/17/2019
Anti-depressant medication side effect monitoring dated 6/1/2020
Review of the residents eMAR revealed that the resident had been given citalopram and trazodone,
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
106006
If continuation sheet
Page 6 of 7
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
106006
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/09/2020
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Baldomero Lopez Memorial Veterans Nursing Home
6919 Parkway Blvd
Land O Lakes, FL 34639
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0758
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
both for depression, daily for the past 3 months and was being monitored for side effects only every shift
and not for the effectiveness of the medication.
Part of the resident's care plan included to be at risk for complications and side effects from daily
administration of psychotropic medications. One of the approaches to this problem area included monitor
for effectiveness. Another approach was Monitor resident frequently for mood or behaviors.
Review of the residents eMAR (electronic medication administration record) revealed that the resident was
not being monitored for effectiveness or behaviors, only side effects.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
106006
If continuation sheet
Page 7 of 7